Search

everythinglearnresearchcommunity

for

Search:↓

Taking 1mg finasteride tablets for 6 months can lower good cholesterol (HDL) and raise triglycerides in men with hair loss.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Finasteride may lower cholesterol and slow heart disease progression.

Certain genetic mutations can lower bad cholesterol and reduce heart disease risk, leading to effective cholesterol-lowering drugs.

Higher Alarin levels may predict androgenetic alopecia and metabolic syndrome.

Psoriasis, acne, and hair loss are linked to unhealthy cholesterol levels, increasing heart disease risk.

Osteopontin levels are higher in people with androgenetic alopecia and are linked to metabolic disorders.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Men with early-onset baldness may have a higher risk of heart disease.

People with more than 11 skin tags, especially on the thigh, neck, or armpit, may have a higher chance of metabolic syndrome.

The study concluded that women with female pattern hair loss had higher waist circumference, triglyceride levels, lower HDL, and blood glucose levels compared to those without hair loss.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Bergamot may improve heart health, skin conditions, and mood, but more research is needed to confirm these benefits.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Eating apples can help prevent heart disease, cancer, and other conditions because they have healthy plant chemicals.

Curcumin improved some metabolic factors in women with PCOS but did not affect cholesterol, insulin, or testosterone levels.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

Type 2 diabetes in youth is increasing, with high treatment failure rates and more severe than Type 1; certain drugs can lower lipid levels effectively with varying side effects, and apples may benefit heart health like statins but with fewer side effects.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Cinnamon can help manage symptoms of polycystic ovary syndrome, improve menstrual cycles and fertility, and positively affect cholesterol and blood sugar levels, but more research is needed to confirm these effects and find the best dosage.

Ganoderma lucidum powder may help prevent skin cancer and lower cholesterol.

Taking a probiotic supplement twice a day improved hair growth, skin hydration, and metabolic health in adults at risk of metabolic syndrome.